Skip to main content
. 2025 Mar 28;45(5):271–282. doi: 10.1007/s40261-025-01432-z
In this study of isavuconazole real-life use performed in 102 patients, off-label use of the drug for empirical therapy or prophylaxis was frequent (24.5%).
Isavuconazole tolerance was overall good, but liver function test disturbances were reported in 11.1% of patients.
Drug exposure was within target range in only 46% of patients.